SavedAdd your journal

Journals / Journal of Anatolian Medical Research / 2026 / Cilt: 11 Sayı: 2

Duchenne Muscular Dystrophy with Recurrent Cardioembolic Stroke: A Case Highlighting Thromboembolic Risks

Tekrarlayan Kardiyoembolik İnme ile Seyreden Duchenne Musküler Distrofisi: Tromboembolik Risklere Dikkat Çeken Bir Olgu

Duygu Yücel(Kayseri Şehir Hastanesi)0009-0005-0265-2971
Hürmet Başkal(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, KAYSERİ ŞEHİR SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ)0009-0000-6161-5840
Ali Sönmez(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, KAYSERİ ŞEHİR SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ)0000-0003-1500-5472
Mehmet Fatih Göl(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, KAYSERİ ŞEHİR SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ)0000-0001-7773-641X
Pages
48–50
Publication Date
2026-08-31
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We present a young adult with prior stroke who developed recurrent ischemic stroke after temporarily stopping antiplatelet therapy for dental treatment, highlighting the importance of continued antithrombotic therapy and multidisciplinary follow-up.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Cardiomyopathy in Duchenne Muscular Dystrophy may increase cardioembolic stroke risk due to intracardiac thrombus formation.
📊
Key Findings & Data:Cardiomyopathy in Duchenne Muscular Dystrophy may increase cardioembolic stroke risk due to intracardiac thrombus formation.
💡
Conclusion & Impact:We present a young adult with prior stroke who developed recurrent ischemic stroke after temporarily stopping antiplatelet therapy for dental treatment, highlighting the importance of continued antithrombotic therapy and multidisciplinary follow-up.
🔬Design:Olgu Sunumu
📍Scope:Comprehensive Sample
⚙️Variables:Antitrombotik tedavi · Duchenne musküler distrofi · Kardiyoembolik inme

Abstract

Cardiomyopathy in Duchenne Muscular Dystrophy may increase cardioembolic stroke risk due to intracardiac thrombus formation. We present a young adult with prior stroke who developed recurrent ischemic stroke after temporarily stopping antiplatelet therapy for dental treatment, highlighting the importance of continued antithrombotic therapy and multidisciplinary follow-up.

Özet

Duchenne musküler distrofisinde gelişen kardiyomiyopati, intrakardiyak trombüs oluşumuna bağlı olarak kardiyoembolik inme riskini artırabilir. Bu olgu sunumunda, daha önce inme öyküsü bulunan genç bir erişkinde, diş tedavisi nedeniyle antiplatelet tedavinin geçici olarak kesilmesini takiben gelişen tekrarlayan iskemik inme ele alınmakta; sürekli antitrombotik tedavinin ve multidisipliner izlemin önemi vurgulanmaktadır.

🔖

Cite This Article

Yücel, D., Başkal, H., Sönmez, A., Göl, M. F. (2026). Duchenne Muscular Dystrophy with Recurrent Cardioembolic Stroke: A Case Highlighting Thromboembolic Risks. Journal of Anatolian Medical Research, Cilt: 11 Sayı: 2, 48–50. https://doi.org/10.55694/jamer.1847256

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. Sarnat HB. Muscular dystrophies. In: Behrman RE, Kliegman RM, Jenson HB, edi-tors. Nelson textbook of pediatrics. 17th ed. Philadelphia (PA): Saunders; 2004. p. 2060-2069.
  2. McNally EM, Towbin JA. Cardiomyopathy in muscular dystrophy workshop. 28-30 September 2003, Tucson, Arizona. Neuromuscul Disord. 2004;14(7):442-448.
  3. Muntoni F. Cardiac complications of childhood myopathies. J Child Neurol. 2003;18(3):191-202.
  4. Finsterer J, Stöllberger C. The heart in human dystrophinopathies. Cardiology. 2003;99(1):1-19.
  5. Dellefave LM, McNally EM. Cardiomyopathy in neuromuscular disorders. Progress in Pediatric Cardiology. 2007;24(1):35-46.
  6. English KM, Gibbs JL. Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders. Dev Med Child Neurol. 2006;48(3):231-235.
  7. Muntoni F. Cardiomyopathy in muscular dystrophies. Curr Opin Neurol. 2003;16(5):577-583.
  8. Kılıç Z. Nöromuskuler hastalıklarda kardiak etkilenme. Türkiye Klinikleri Pediatri Özel Dergisi. 2003;1(3):263-267.
  9. Nigro G, Comi LI, Politano L, Bain RJI. The incidence and evolution of cardiomyo-pathy in Duchenne muscular dystrophy. Int J Cardiol. 1990;26(3):271-277.
  10. Hsu DT. Cardiac manifestations of neuromuscular disorders in children. Paediatr Res-pir Rev. 2010;11(1):35-38.
  11. Biller J, Ionasescu V, Zellweger H, Adams HP Jr, Schultz DT. Frequency of cerebral infarction in patients with inherited neuromuscular diseases. Stroke. 1987;18(4):805-807.
  12. Hanajima R, Kawai M. Incidence of cerebral infarction in Duchenne muscular dyst-rophy. Muscle Nerve. 1996;19(7):928.
  13. Winterholler M, Holländer C, Kerling F, Weber I, Dittrich S, Türk M, et al. Stroke in Duchenne muscular dystrophy: a retrospective longitudinal study in 54 patients. Stro-ke. 2016;47(8):2123-2126.
  14. Tsakadze N, Katzin LW, Krishnan S, Behrouz R. Cerebral infarction in Duchenne muscular dystrophy. J Stroke Cerebrovasc Dis. 2011;20(3):264-265.
  15. Gimenez-Muñoz A, Capablo JL, Alarcia R, Torné L, Errea JM. Intracardiac thrombus and cerebral infarction in a patient with Duchenne muscular dystrophy. J Clin Neuro-muscul Dis. 2009;11(2):79-80.
  16. Ikeniwa C, Sakai M, Kimura S, Wakayama T, Kuru S, Yasuma F, et al. [Two cases of Duchenne muscular dystrophy complicated with dilated cardiomyopathy and cerebral infarction]. No To Shinkei. 2006;58(3):250-255.
  17. Díaz Buschmann C, Ruiz Falcó ML, Tamariz Martel Moreno A, García Peñas JJ, Gu-tiérrez Solana LG, Pérez Jiménez A, et al. [Repeated cerebral infarction in a patient with Duchenne’s muscular dystrophy]. Rev Neurol. 2004;38(6):533-536.
  18. Douketis JD, Spyropoulos AC, Murad MH, Arcelus JI, Dager WE, Dunn AS, et al. Perioperative management of antithrombotic therapy: an American College of Chest Physicians clinical practice guideline. Chest. 2022;162(5):e207-e243.
  19. Connors JM. Thrombophilia testing and venous thrombosis. N Engl J Med. 2017;377:1177-1187.